Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TECH stock hub

Bio-Techne Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TECHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.6B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TECH

In the news

Latest news · TECH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.1

P25 12.3P50 18.4P75 33.1

Trailing P/E69.6

P25 14.9P50 23.2P75 38.5

ROE5.3

P25 -105.6P50 -46.5P75 -3.1

ROIC10.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TECH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

285

Groups with data

Currency

USD

Showing 285 of 285 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000842023
Company name	Bio-Techne Corporation
Country	United States
Country code	US
Cusip	09073M104
Employees	3,100
Employees Change	0%
Employees Change Percent	0
Enterprise value	$7.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Biotechnology
IPO Date	1989-02-09
Isin	US09073M1045
Last refreshed	2026-05-10
Market cap	$7.6B
Market cap category	Mid-Cap
Price	$48.36
Price currency	USD
Rev Per Employee	390,584.19x
Sector	Healthcare
Sic	2836
Symbol	TECH
Website	https://www.bio-techne.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.45%
EV Earnings	69.84x
EV Sales Forward	5.85x
EV/EBIT	24.69x
EV/EBITDA	20.89x
EV/FCF	28.37x
EV/Sales	6.32x
FCF yield	3.56%
Forward P/E	24.05x
P/B ratio	3.63x
P/E ratio	69.61x
P/S ratio	6.25x
PE Ratio10 Y	64.44x
PE Ratio3 Y	75.05x
PE Ratio5 Y	74.31x
PEG ratio	3.34x
PS Forward	5.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.58%
EBITDA Margin	30.23%
FCF margin	22.27%
Gross margin	66.4%
Gross Profit	$804M
Gross Profit Growth	-0.13%
Gross Profit Growth Q	-2.63%
Gross Profit Growth3 Y	1.63%
Gross Profit Growth5 Y	7.11%
Net Income	$109.5M
Net Income Growth	-16.79%
Net Income Growth Q	125.99%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	-26.09%
Net Income Growth5 Y	-9.87%
Pretax Margin	12.15%
Profit Margin	9.05%
Profit Per Employee	$35,322
Profitable Years	33
ROA	7.45
Roa5y	6.84
ROCE	12.92
ROE	5.34
Roe5y	10.62
ROIC	10.62
Roic5y	11.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.39%
Cagr15y	7.2%
Cagr1y	-0.22%
Cagr20y	7.39%
Cagr3y	-16.11%
Cagr5y	-14.12%
Div CAGR10	0%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-16.3
EPS Growth Q	128.6
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	-25.49
EPS Growth5 Y	-9.56
FCF Growth	22.13%
FCF Growth Q	150.27%
FCF Growth3 Y	5.02%
FCF Growth5 Y	3.72%
OCF Growth	11.33%
OCF Growth Q	110.75%
OCF Growth10 Y	7.38%
OCF Growth3 Y	2.51%
OCF Growth5 Y	1.41%
Revenue Growth	0.17x
Revenue Growth Q	-1.51x
Revenue Growth Years	12x
Revenue Growth3 Y	2.52x
Revenue Growth5 Y	7.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.47
Assets	$2.6B
Cash	$214.1M
Current Assets	$688.1M
Current Liabilities	$153.3M
Debt	$290.3M
Debt EBITDA	$0.75
Debt Equity	$0.14
Debt FCF	$1.08
Equity	$2.1B
Interest Coverage	31.98
Liabilities	$465.3M
Long Term Assets	$1.9B
Long Term Liabilities	$312M
Net Cash	$-76.2M
Net Cash By Market Cap	$-1.01
Net Debt EBITDA	$0.21
Net Debt Equity	$0.04
Net Debt FCF	$0.28
Tangible Book Value	$788.4M
Tangible Book Value Per Share	$5.04
WACC	11.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.49
Inventory Turnover	2.07
Net Working Capital	$334.8M
Quick ratio	2.8
Working Capital	$534.8M
Working Capital Turnover	$2.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.32%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$0.32
Dividend Years	19
Dividend Yield	0.66%
Ex Div Date	2026-05-18
Last Dividend	$0.08
Payout Frequency	Quarterly
Payout Ratio	46.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	104.03%
1Y total return	-0.22%
200-day SMA	58.1
3Y total return	-40.97%
50-day SMA	54.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-53.29%
All Time High	136
All Time High Change	-64.43%
All Time High Date	2021-09-23
All Time Low	0.55
All Time Low Change	8,742.57%
All Time Low Date	1994-08-03
ATR	3.27
Beta	1.4
Beta1y	1.35
Beta2y	1.02
Ch YTD	-17.77
High	50.5
High52	72.16
High52 Date	2026-01-22
High52ch	-32.98%
Low	47.85
Low52	45.12
Low52 Date	2026-05-06
Low52ch	7.19%
Ma50ch	-10.77%
Premarket Change Percent	-0.37
Premarket Price	$50.72
Premarket Volume	10,042
Price vs 200-day SMA	-16.77%
RSI	39.52
RSI Monthly	39.54
RSI Weekly	39.43
Sharpe ratio	0.14x
Sortino ratio	0.32
Total Return	2.98%
Tr YTD	-17.66
Tr15y	183.93%
Tr1m	-10.16%
Tr1w	-12.1%
Tr3m	-27.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	1
Analyst Price Target Top	$65
Analyst Ratings	Strong Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.52
Earnings EPS Estimate Growth	-7.14
Earnings Revenue Estimate	316,634,752x
Earnings Revenue Estimate Growth	0.14x
Operating Income	$309.7M
Operating Income Growth	41.8
Operating Income Growth Q	98.42
Operating Income Growth3 Y	6.24
Operating Income Growth5 Y	8.33
Operating margin	25.58
Price target	$69.27
Price Target Change	$43.24
Price Target Change Top	$34.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,661,627%
Float Percent	98.78%
Net Borrowing	-130,000,000
Shares Insiders	1.14%
Shares Institutions	116.79%
Shares Out	156,568,751
Shares Qo Q	0.26%
Shares Yo Y	-2.32%
Short Float	9.05%
Short Ratio	6.75
Short Shares	8.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$228.9M
Average Volume	2,786,270.9x
Bv Per Share	13.32
CAPEX	$-25.3M
Ch10y	91.69
Ch15y	147.4
Ch1m	-10.16
Ch1w	-12.1
Ch1y	-0.8
Ch20y	247.5
Ch3m	-27.58
Ch3y	-41.83
Ch5y	-54.28
Ch6m	-15.76
Change	-5.01%
Change From Open	-3.32
Close	50.91
Days Gap	-1.75
Depreciation Amortization	56,329,000
Dollar Volume	180,711,744.7
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$309.7M
EBITDA	$366M
EPS	$0.69
F Score	7
FCF	$269.6M
FCF EV Yield	3.53x
FCF Per Share	$1.72
Financing CF	-226,358,000
Fiscal Year End	June
Founded	1,976
Goodwill	977,800,000
Graham Number	14.43086
Graham Upside	-70.16
Income Tax	$37.6M
Investing CF	-10,727,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2022-11-30
Last Split Type	Forward
Last10k Filing Date	2025-08-22
Lynch Fair Value	$3.47
Lynch Upside	-92.82
Ma150	59.43
Ma150ch	-18.63%
Ma20	55.28
Ma20ch	-12.51%
Net CF	69,149,000
Next Earnings Date	2026-08-05
Open	50.02
Optionable	Yes
P FCF Ratio	28.09
P OCF Ratio	25.68
Payment Date	2026-05-29
Position In Range	19.25
Post Close	48.36
Postmarket Change Percent	0.95
Postmarket Price	$48.82
Ppne	301,306,000
Pre Close	50.91
Price Date	2026-05-08
Price EBITDA	$20.69
Ptbv Ratio	9.6
Relative Volume	1.34x
Revenue	1,210,811,000x
SBC By Revenue	3.36x
Share Based Comp	40,685,000
Tax By Revenue	3.1x
Tax Rate	25.54%
Tr20y	315.88%
Tr6m	-15.54%
Us State	Minnesota
Volume	3,736,802
Z Score	13.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TECH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.32 annual per share

Payout ratio

+46.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2026-05-18

Performance

TECH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TECH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+116.8%

Float: +98.8% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TECH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.5

Neutral momentum band

Price vs 200-day MA

-16.8%

50/200-day relationship not available

Beta (5Y)

1.40

More volatile than the market

Sharpe ratio

0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TECH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TECH stock rating?

Bio-Techne Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TECH analysis?

The full report lives at /stocks/TECH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TECH?

The latest report frames TECH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TECH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.